Related Experiment Video
Updated: Jun 28, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis
1University of Leicester, Brandon Unit Leicester General Hospital, Leicester LE54PW, UK. alex.mitchell@leicspart.nhs.uk
Background:
Mild cognitive impairment (MCI) is a condition that carries a substantial risk of dementia. The exact magnitude of that risk is uncertain because of the variations in the definition of MCI, the setting (such as memory clinic versus community) and, equally importantly, the duration of follow-up. Recently, a number of long term studies have been published with observation periods of 5 years of longer.
Methods:
In this quantitative review, 15 long term studies were examined and compared with the results from studies using shorter periods of observation, focusing on the annual conversion rate (ACR) of MCI to dementia.
Results:
The report identified six long term clinical studies conducted in specialist settings and nine long term population studies conducted in the community. Across all cohort studies with completed follow-up, the mean ACR to dementia was 4.2% (95% CI 3.9% to 4.6%). This was lower than the rate reported in studies of less than 5 years' duration. The cumulative conversion rate averaged 31.4% in this sample. The proportion converting to dementia (and Alzheimer's disease) declined with longer observation periods, suggesting that risk of progression diminishes with time.
Conclusion:
A 10-15% ACR only appears to hold true in clinical samples monitored over a short observation period. Recruitment of older individuals from specialist centres, particularly involving those who complain of cognitive difficulties (subjective memory complaints) will tend to favour high conversion rates. In the first few years of follow-up, many of those with the most adverse risk profile will tend to progress, dropout or die, leaving a cohort of less vulnerable sufferers. However, an inverse temporal relationship was also manifest in those who completed long term follow-up, suggesting other factors are involved such as sampling issues or heterogeneity in MCI itself.
Insights
The annual conversion rate of mild cognitive impairment (MCI) to dementia is lower in long-term studies compared to short-term ones. Progression risk diminishes over time, especially in community-based studies.
Area of Science:
- Neurology
- Geriatrics
- Epidemiology
Background:
- Mild cognitive impairment (MCI) significantly increases dementia risk.
- Variations in MCI definition, study setting, and follow-up duration create uncertainty in risk magnitude.
- Recent long-term studies (≥5 years) offer more reliable data on MCI progression.
Purpose of the Study:
- To quantitatively review long-term studies on MCI conversion to dementia.
- To compare annual conversion rates (ACR) in long-term versus short-term studies.
- To assess the impact of follow-up duration on MCI progression to dementia.
Main Methods:
- Quantitative review of 15 long-term studies (≥5 years).
- Comparison with shorter observation period studies.
- Focus on annual conversion rate (ACR) of MCI to dementia.
Main Results:
- Mean ACR to dementia across all cohort studies was 4.2% (95% CI 3.9% to 4.6%).
- Long-term studies showed lower ACR compared to short-term studies.
- Cumulative conversion rate averaged 31.4%; progression declined with longer follow-up.
Conclusions:
- High ACR (10-15%) is typically observed in short-term clinical samples.
- Specialist settings and subjective memory complaints may inflate short-term conversion rates.
- Long-term follow-up reveals diminishing progression risk, though sampling and MCI heterogeneity may influence findings.
Related Concept Videos
Alzheimer Disease l: Introduction
Dementia l: Introduction
Dementia
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Development During Adulthood
